Incyte Corporation
NASDAQ: INCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William J. Meury
- Employees
- 2,617
- Headquarters
- Wilmington, United States
- IPO year
- 1993
- Market cap
- $19.6B
- Website
- https://www.incyte.com
Loading INCY…
Loading profile data…Frequently asked questions about INCY
What does Incyte Corporation (INCY) do?
Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liqui...
Where does INCY trade?
Incyte Corporation (INCY) trades on the NASDAQ Global Select.
What sector is INCY in?
Incyte Corporation (INCY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Incyte Corporation?
William J. Meury is the chief executive officer of Incyte Corporation (INCY).
Where is Incyte Corporation headquartered?
Incyte Corporation is headquartered in United States.
Does INCY pay a dividend?
Incyte Corporation (INCY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INCY go public?
Incyte Corporation (INCY) completed its initial public offering in 1993.